… Symptoms: Rapid deterioration of heart failure, suspected fulminant myocarditis or giant
cell myocarditis or sarcoid heart disease or ventricular tachycardia of unknown origin …

… therapeutic outcomes of fulminant myocarditis treated with … a therapeutic guidelines for
fulminant myocarditis using PCPS. … survival rate of fulminant myocarditis patients were published. …

… (GCM) is a form of rapidly progressing necrotizing myocarditis responsible for 0.5% of
myocarditis and 10% of all fulminant myocarditis [82]. This condition is characterized by the …

… 1. The general pathophysiological process of common myocarditis could be divided into
three … When patients with fulminant myocarditis clear the virus through host immune defense …

… fulminant myocarditis and 132 had acute myocarditis. Over 11 years of follow-up, 93% of
those who had fulminant myocarditis … with 45% of those in the acute myocarditis category (Fig. …

… , opening new avenues for the management of patients critically ill with COVID-19 with
fulminant myocarditis because complete recovery of the myocardial function can be expected. …

… a fulminant presentation … myocarditis at clinical, biomolecular and histopathological levels.
We then discuss recent insights on the role of specific immune cell populations in myocarditis …

… 5 Long-term outcome of fulminant myocarditis as compared with acute (non-fulminant) … Of
the 22 children treated for either cardiomyopathy or fulminant myocarditis within this group, 91…

… viral myocarditis in humans is lymphocytic myocarditis associated with cardiac necrosis,
which may lead to self-limiting acute disease or a life-threatening fulminant form of myocarditis. …

… role in this inflammatory process leading to delivery of interleukin-1 beta [33]. Complete
depletion of macrophages in viral myocarditis is associated with increased mortality. In contrast …